Delivery Order SPE2DB24D1104-SPE2DB25FXTV5

Award Date 10/28/24
Potential Completion Date 10/29/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Valsartan-HCTZ 320-25 mg tablets. The contract has a ceiling value of $1,211.54 and is a firm fixed-price delivery order without a set-aside designation. The period of performance for this order extends to July 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Valsartan-HCTZ 320-25 mg tablets in 90-count bottles. The $6,429.84 firm-fixed-price contract has a completion date of February 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Valsartan-HCTZ 320-25 mg tablets in 90-count packages. The contract has a firm fixed price of $4,368.55 and a period of performance through April 12, 2024. This delivery order is issued under a larger indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,492.67, is for the delivery of Valsartan-HCTZ 320-25 mg tablets in 90 count packages. The contract has a period of performance through July 9, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4,564,098,042 Valsartan-HCTZ 160-12.5 mg tablets in 90-count packages. The contract has a total ceiling value of $6,394.83 and an ultimate completion date of March 28, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,308.36, is for the delivery of Valsartan-HCTZ 80-12.5 mg tablets in 90-count bottles. The contract has an ultimate completion date of January 8, 2025 and is structured as a firm fixed price contract. Amerisourcebergen Drug Corp is the prime contractor, and there is no...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $4,450.69, is for the delivery of 4,563,926,962 units of the pharmaceutical product Valsartan-HCTZ 320-25 mg Tablets, with a period of performance through March 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $2,578.30, is for the delivery of Valsartan-HCTZ 80-12.5 mg tablets in 90-count packages. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of Valsartan-HCTZ 160-25 mg tablets in 90-count quantities, with a ceiling value of $1,919.31. The contract is a firm fixed-price, non-set-aside award with a performance period extending through April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a $3,615.46 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Valsartan-HCTZ 160-12.5 mg tablets in 90-count packages. The contract has an ultimate completion date of March 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB25FXTV5
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, valued at $1,505.96. The order is for the delivery of Valsartan-HCTZ 320-25 mg tablets in 90 count packages. The order has an ultimate completion date of October 29, 2024 and uses a firm fixed price pricing type. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. No set-aside designation is mentioned for this specific delivery order.

Generated 2/2/25, 12:02 AM